Published in Lab Business Week, November 19th, 2006
In his new position, Strauss will be responsible for overseeing and directing all clinical activities at Omeros, including the ongoing Phase 3 clinical studies for OMS103HP, the company's lead product to reduce pain and improve function following arthroscopic surgery.
Strauss was the therapeutic area vice president and project leader - Arthritis, Inflammation, Pain for Pharmacia where he was in charge of Pharmacia's development efforts across each of those therapeutic areas, including anti-inflammatory drugs and an anti-TNF-alpha...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.